LAMPERT MARK N Top 13F Holdings

Contact Info

lampert mark n
1 SANSOME ST
SAN FRANCISCO CA 94104
Business Phone: 3125066500

SEC SIC CODE:
8731-SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

Catalyst Biosciences Inc - Other Owner (08/20/2015)
Ligand Pharmaceuticals, Inc. - Other Owner (03/24/2014)
ChemoCentryx, Inc. - Other Owner (11/03/2015)
Array Biopharma Inc - Other Owner (07/01/2014)
Facet Biotech - >10% Owner (02/05/2010)
Dynavax Technologies Corp - >10% Owner (09/10/2009)
Adolor Corp - >10% Owner (09/22/2009)
ArQule, Inc. - >10% Owner (05/30/2018)
Neurobiological Technologies Inc - >10% Owner (10/21/2009)
Avigen Inc. - >10% Owner (11/18/2009)
Medicinova Inc - >10% Owner (12/18/2009)
EPIRUS BIOPHARMACEUTICALS INC COM - >10% Owner (12/22/2009)
Neurocrine Biosciences Inc. - Other Owner (02/09/2012)
Astex Pharmaceuticals Inc. - >10% Owner (04/19/2010)
Celera Group - >10% Owner (05/13/2011)
Capstone Therapeutics Corp - Other Owner (07/14/2017)
Icagen - >10% Owner (09/07/2011)
Palatin Technologies Inc - >10% Owner (02/27/2014)
Kent International Holdings - Other Owner (12/23/2011)
Rigel Pharmaceuticals Inc - >10% Owner (11/19/2013)
Cascadian Therapeutics, Inc. - Director (06/23/2016)
Regado BioSciences, Inc. - Other Owner (03/21/2014)
CTI BioPharma Corp - >10% Owner (04/01/2021)
Xenon Pharmaceuticals Inc - >10% Owner (03/27/2018)
Infinity Pharmaceuticals Inc - Other Owner (02/17/2021)
Xoma Corporation - >10% Owner (03/31/2021)
Alpine Immune Sciences Inc - >10% Owner (06/20/2017)
GlycoMimetics Inc - >10% Owner (11/04/2020)
Concert Pharmaceuticals Inc - >10% Owner (06/10/2019)
Regulus Therapeutics Inc - >10% Owner (11/17/2017)
Syndax Pharmaceuticals Inc - >10% Owner (06/18/2018)
Repligen Corp. - >10% Owner (07/06/2009)
Immune Design Corp - >10% Owner (12/04/2018)
Pieris Pharmaceuticals Inc - >10% Owner (09/06/2019)
Calithera Biosciences Inc - >10% Owner (05/21/2020)
Five Prime Therapeutics Inc - >10% Owner (03/04/2021)
Cytokinetics Inc - Other Owner (12/09/2020)
Merus BV - >10% Owner (03/30/2021)
Ideaya Biosciences Inc - Other Owner (02/02/2021)
Principia Biopharma Inc - >10% Owner (08/18/2020)
Kymera Therapeutics, Inc. - Other Owner (08/20/2020)
Eledon Pharmaceuticals Inc - Other Owner (12/22/2020)
SA VCP Dynamic Allocation Portfolio-Class 3 - >10% Owner (11/18/2020)
Olema Pharmaceuticals, Inc. - >10% Owner (11/18/2020)
CytomX Therapeutics Inc - Other Owner (01/25/2021)

LAMPERT MARK N

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments

LAMPERT MARK N

Email Notification.

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments